The Christie NHS Foundation Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- -
- Established
- 2007-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.christie.nhs.uk/
Temozolomide in Treating Women With Advanced Breast Cancer
Phase 2
- Conditions
- Breast Cancer
- First Posted Date
- 2004-06-08
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Registration Number
- NCT00005054
- Locations
- π¬π§
Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin
Phase 3
- Conditions
- Carcinoma of Unknown Primary
- First Posted Date
- 2004-02-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Registration Number
- NCT00022178
- Locations
- π¬π§
Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
Phase 3
- Conditions
- Lung Cancer
- First Posted Date
- 2003-07-24
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Registration Number
- NCT00004887
- Locations
- π¬π§
Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom
Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 2
- Conditions
- Lung Cancer
- First Posted Date
- 2003-06-12
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Registration Number
- NCT00022009
- Locations
- π¬π§
Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom
Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin
Phase 3
- Conditions
- Lung Cancer
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Target Recruit Count
- 400
- Registration Number
- NCT00055965
- Locations
- π¬π§
Christie Hospital NHS Trust, Manchester, England, United Kingdom
Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
Phase 2
- Conditions
- Kidney Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- The Christie NHS Foundation Trust
- Registration Number
- NCT00005038
- Locations
- π¬π§
Christie Hospital N.H.S. Trust, Manchester, England, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath